Literature DB >> 12810648

Assignment of 1H nuclear magnetic resonance visible polyunsaturated fatty acids in BT4C gliomas undergoing ganciclovir-thymidine kinase gene therapy-induced programmed cell death.

Julian L Griffin1, Kimmo K Lehtimäki, Piia K Valonen, Olli H J Gröhn, Mikko I Kettunen, Seppo Ylä-Herttuala, Asla Pitkänen, Jeremy K Nicholson, Risto A Kauppinen.   

Abstract

Polyunsaturated fatty acids (PUFAs), as detected by (1)H nuclear magnetic resonance (NMR) spectroscopy, accumulate into BT4C glioma during ganciclovir-thymidine kinase gene therapy-induced programmed cell death (PCD). In this study, we have quantified the (1)H NMR visible lipids in vivo and characterized their biophysical and biochemical nature in these tumors during PCD both ex vivo and in vitro. Concentrations of (1)H NMR-detectable PUFAs increased 3-fold with pattern recognition identifying CH = CH and CH = CHCH(2)CH = CH as the most significant in monitoring the dynamics of PCD. The increase in PUFAs was equivalent to 70% of that in CH(2)CH(2)CH(2)-saturated lipid peak at 1.3 ppm. Ex vivo tumor samples, obtained from in situ funnel frozen tumors, showed very similar macromolecular peaks, as studied using high-resolution magic angle spinning (1)H NMR at 14.1 T, to those detected in vivo at 4.7 T. Line widths of lipid peaks were not influenced by the spin rate within the range of 1-9 kHz or temperature between 277 and 293 K, showing high degree of (1)H NMR detection of these peaks in vivo. These biophysical results additionally corroborate the idea that cytoplasmic lipid vesicles are the source of (1)H NMR lipid signals. Two-dimensional (1)H NMR ex vivo and tumor lipid extracts in vitro showed that the PUFA signals are in the same chemical compounds and consist of largely 18:1 and 18:2 lipids. Furthermore, it is suggested that the (1)H NMR lipids detected during PCD arise from cell constituent breakdown products forming lipid vesicles into dying cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12810648

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  46 in total

1.  NMR-based metabolomic analysis of the molecular pathogenesis of therapy-related myelodysplasia/acute myeloid leukemia.

Authors:  Kristin E Cano; Liang Li; Smita Bhatia; Ravi Bhatia; Stephen J Forman; Yuan Chen
Journal:  J Proteome Res       Date:  2011-05-11       Impact factor: 4.466

Review 2.  The application of NMR-based metabonomics in neurological disorders.

Authors:  Elaine Holmes; Tsz M Tsang; Sarah J Tabrizi
Journal:  NeuroRx       Date:  2006-07

3.  A high spatial resolution 1H magnetic resonance spectroscopic imaging technique for breast cancer with a short echo time.

Authors:  Jiani Hu; Yingjian Yu; Zhifeng Kou; Wei Huang; Quan Jiang; Yang Xuan; Tao Li; Vivek Sehgal; Cassann Blake; E Mark Haacke; Renate L Soulen
Journal:  Magn Reson Imaging       Date:  2007-09-27       Impact factor: 2.546

Review 4.  The Cinderella story of metabolic profiling: does metabolomics get to go to the functional genomics ball?

Authors:  Julian L Griffin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-01-29       Impact factor: 6.237

Review 5.  Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas.

Authors:  Rolf F Barth; Balveen Kaur
Journal:  J Neurooncol       Date:  2009-04-21       Impact factor: 4.130

6.  Noninvasive temperature mapping with MRI using chemical shift water-fat separation.

Authors:  Brian J Soher; Cory Wyatt; Scott B Reeder; James R MacFall
Journal:  Magn Reson Med       Date:  2010-05       Impact factor: 4.668

7.  Artificial neural networks for classification in metabolomic studies of whole cells using 1H nuclear magnetic resonance.

Authors:  D F Brougham; G Ivanova; M Gottschalk; D M Collins; A J Eustace; R O'Connor; J Havel
Journal:  J Biomed Biotechnol       Date:  2010-09-15

8.  Taurine: a potential marker of apoptosis in gliomas.

Authors:  K S Opstad; B A Bell; J R Griffiths; F A Howe
Journal:  Br J Cancer       Date:  2009-02-17       Impact factor: 7.640

9.  Time-dependent effects of imatinib in human leukaemia cells: a kinetic NMR-profiling study.

Authors:  J Klawitter; N Anderson; J Klawitter; U Christians; D Leibfritz; S G Eckhardt; N J Serkova
Journal:  Br J Cancer       Date:  2009-03-03       Impact factor: 7.640

10.  ¹H nuclear magnetic resonance spectroscopy characterisation of metabolic phenotypes in the medulloblastoma of the SMO transgenic mice.

Authors:  S K Hekmatyar; M Wilson; N Jerome; R M Salek; J L Griffin; A Peet; R A Kauppinen
Journal:  Br J Cancer       Date:  2010-09-14       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.